COMMUNIQUÉS West-GlobeNewswire

Nova Leap Health Corp. announces Closing of Home Care Acquisition in Nova Scotia
06/05/2025
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, May 06, 2025 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) ("Nova Leap" or “the Company”), a [...]
Sofwave Medical Reports First Quarter Fiscal 2025 Financial Results and Business Highlights
06/05/2025
— First quarter revenue of $1 6.7 M, +2 6 % year-over-year growth; IFRS gross margin of 7 6.3 % — First quarter pulse recurring revenue of $ 7.0 M , + 49 % year-over-year growth — IFRS and non-IFRS operating loss of -$ [...]
Palisade Bio Presents Positive Preclinical Data Highlighting Potential of PALI-2108 as a Promising Colon-Specific PDE4 Inhibitor for the Treatment of Ulcerative Colitis and Other Inflammatory Bowel Diseases
06/05/2025
Two posters presented at Digestive Disease Week (DDW) 2025 Preclinical results indicate that PALI-2108 effectively modulates inflammatory pathways in the colon, promoting a favorable immune response Company advancing [...]
Intelligent Bio Solutions Drives Global Growth Through Multilingual Digital Expansion
06/05/2025
Arabic, Italian, and Spanish-language websites unlock commercial access to regions representing over 1.4 billion people Multilingual rollout aligns with product readiness and accelerates international sales pipeline [...]
Allogene Therapeutics to Report First Quarter 2025 Financial Results and Provide Business Update
06/05/2025
Conference Call and Webcast Scheduled for May 13, 2025 at 2:00 p.m. PT/5:00 p.m. ET SOUTH SAN FRANCISCO, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage [...]
Achieve Life Sciences to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 13, 2025
06/05/2025
SEATTLE and VANCOUVER, British Columbia, May 06, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV) a late-stage specialty pharmaceutical company focused on the global development and commercialization [...]
Viemed Executes Diversification Strategy With $26 Million Acquisition of Home Equipment Provider in Illinois
06/05/2025
LAFAYETTE, La., May 06, 2025 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ: VMD), an in-home clinical care provider of post-acute respiratory healthcare equipment and services in the [...]
Alpha Tau to Participate in May Investor Conferences
06/05/2025
JERUSALEM, May 06, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT ® , today announced [...]
CytoDyn Appoints Biotech Veteran Robert E. Hoffman as Chief Financial Officer
06/05/2025
VANCOUVER, Washington, May 06, 2025 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple [...]
Digital Utilities Ventures CEO Mark Gaalswyk Meets with QFFD in Qatar
06/05/2025
Easy Environmental Solutions, Inc. Enters Strategic Talks with QFFD and African Governments to Accelerate a New Era of Regenerative Agriculture and Clean Water Infrastructure Strategic Partnership with QFFD to Transform [...]
SRx Health Solutions to Host First Quarter 2025 Financial Results Conference Call on May 15th at 4:30 p.m. ET
06/05/2025
TAMPA, Fla., May 06, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”), a leading global health and wellness company, today announced it will host a conference call and webcast on [...]
Imprivata Wins Global InfoSec Awards in Passwordless Authentication and Third Party Risk Categories
06/05/2025
WALTHAM, Mass., May 06, 2025 (GLOBE NEWSWIRE) -- Imprivata , the digital identity company for life- and mission-critical industries, today announced that the company has won two Global InfoSec Awards 2025 , presented by [...]
Priothera Appoints Dr. Jens Hasskarl as Chief Medical Officer to Drive Late-Stage Clinical Development of Mocravimod, a S1P Receptor Modulator for Acute Myeloid Leukemia (AML)
06/05/2025
Dr. Hasskarl to lead global Phase 3 MO-TRANS study evaluating mocravimod as an adjunctive treatment to allo-HCT in AML Saint-Louis, France and Dublin, Ireland – 6 th May 2025 – Priothera Ltd., a late-stage biopharma [...]
Essential Pharma strengthens management team with appointment of Duncan Ferguson as Vice President, Commercial
06/05/2025
Egham, UK – 6th May 2025 – Essential Pharma (“Essential” or “the Company”), a global pharmaceutical company developing and delivering medicines for patients in niche populations, today announces the appointment of [...]
New Analysis Published in Nature Medicine Demonstrates Advantages of Nationwide Coronary CTA Strategy with Heartflow FFRCT in Over 90,000 Patients with Coronary Artery Disease
06/05/2025
Two-year data from England’s National Health Service show improved care efficiency with reduction in unnecessary invasive and noninvasive cardiac tests using CCTA and Heartflow FFRCT versus CCTA alone MOUNTAIN VIEW, [...]
NTG Nordic Transport Group A/S - Q1 2025 Conference Call
06/05/2025
NTG Nordic Transport Group A/S – Q1 2025 Conference Call We expect to release the Q1 2025 results of NTG Nordic Transport Group in the evening of May 12, 2025. A webcast and conference call will be held in the morning [...]
ENA Respiratory Appoints International Pharma Experts as Strategic Advisors to Support Development of INNA-051 Antiviral Host Defence Enhancer
06/05/2025
MELBOURNE, Australia, May 06, 2025 (GLOBE NEWSWIRE) -- ENA Respiratory , a clinical-stage pharmaceutical company developing antiviral host defence enhancers to minimize the impact of viral respiratory infections, [...]
Italfarmaco Announces U.S. FDA Grants Fast Track Designation to Givinostat in Treatment of Polycythemia Vera
06/05/2025
MILAN, Italy, May 6, 2025 – Italfarmaco S.p.A. announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to givinostat for the treatment of patients with polycythemia vera (PV [...]
Mind Lab PRO Under Review: Is Mind Lab Pro® v4.0 Universal Nootropic Brain Booster Safe? Best Nootropics Supplement
06/05/2025
Uncover the truth about Mind Lab Pro® v4.0. Is this universal nootropic safe and effective? Full review of its brain-boosting benefits, ingredients, and real user results Royal Leamington Spa, May 06, 2025 (GLOBE [...]

Pages